Xcout IntelSign inSubscribe

ブライトパス・バイオ

Biotech · Japan

BrightPath Biotherapeutics Co., Ltd. specializes in the development of innovative cancer immunotherapies. Among its leading candidates is GRN-1201, currently undergoing Phase II…

The full profile of ブライトパス・バイオ

Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.

Subscribe to see ブライトパス・バイオ →Already a subscriber? Sign in

Xcout Intel tracks ブライトパス・バイオ continuously — this profile deepens as new filings, funding, people and hiring data arrive.